Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [3] [4] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

  3. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  4. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  5. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  6. Vasant Narasimhan - Wikipedia

    en.wikipedia.org/wiki/Vasant_Narasimhan

    Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical ...

  7. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/2010/12/15/novartis-obtains-final...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  8. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

    Novartis (NYS: NVS) has two things to say. It now expects more bang for its buck from Alcon. The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double ...

  9. AOL

    login.aol.com

    AOL is a leading online service provider that offers free email, news, entertainment, and more. With AOL, you can access your email from any device, customize your inbox, and enjoy a secure and reliable email experience. Sign in to AOL today and discover the benefits of AOL Mail.